90TEN nominated for five Communiqué Awards

90TEN’s work with Novartis on the global launch of Cosentyx® is nominated for Excellence in Media Relations. The agency’s Hepatitis C medical education programme for AbbVie, ‘Revealing a New Face of Cure’, has been shortlisted for Excellence in Communications via a Live Event or Stand Alone Activity. Meanwhile two of the agency’s campaigns for Sirtex - in collaboration with Denovo Strategy - in metastatic colorectal liver cancer are shortlisted, for Excellence in Media Relations and Excellence in Integrated Product/Brand Communications.  

Paul Tanner, Chairman of 90TEN, said: “These five nominations demonstrate 90TEN’s commitment to pushing the boundaries to deliver truly ‘Life.Changing’ work that changes behaviours and improves outcomes. 2015 was a hugely successful year for 90TEN – we grew exponentially, hired some incredible talent, and as you can see here, delivered some impressive work. These nominations are a tribute to the creativity and talent of 90TEN’s growing team and the bravery of the client’s we represent.”  

“I’m particularly proud that Sophie Mansfield has been shortlisted for Young Achiever. Sophie is an amazingly accomplished and passionate communications professional – a future leader of industry – and I wish her every success on the night,” Tanner continued.  

The Communiqué Awards will be presented at London’s Grosvenor House Hotel, Park Lane, on 7 July 2016.

90TEN is a global, independent healthcare communications consultancy that puts people at the heart of everything it does. Its work is designed to make a difference by improving outcomes for patients, healthcare professionals and clients. To learn how we could help you, contact Paul Tanner via paul.tanner@90ten.co.uk or call +44 20 7627 0990.